What is Fuchs' dystrophy?

Written in association with: Mr John Awad
Published:
Edited by: Conor Lynch

Fuchs' dystrophy is a progressive eye disease that affects the cornea, the clear front surface of the eye. Named after the Austrian ophthalmologist Ernst Fuchs, who first described it in 1910, this condition primarily impacts the innermost layer of the cornea, known as the endothelium.

 

The endothelium is responsible for pumping excess fluid out of the cornea to maintain its clarity. In Fuchs' dystrophy, the endothelial cells gradually deteriorate and die off, leading to a buildup of fluid within the cornea. This fluid accumulation causes corneal swelling, clouding, and vision impairment. In this article, Mr John Awad, an esteemed consultant ophthalmologist, details the condition in more detail. 

Causes and risk factors

While the exact cause of Fuchs' dystrophy remains unknown, it is often inherited. The condition usually manifests later in life, with symptoms typically appearing in individuals in their 50s or 60s. Women are more frequently affected than men, and a family history of the disease increases the likelihood of developing it.

 

Symptoms

Early signs of Fuchs' dystrophy may include blurred vision, particularly in the morning, which improves as the day progresses. As the disease advances, vision problems become more persistent.

 

Patients may experience glare, haloes around lights, and a feeling of grittiness or discomfort in the eyes. In severe cases, painful blisters, known as bullae, can form on the corneal surface.

 

Diagnosis

An ophthalmologist can diagnose Fuchs' dystrophy through a comprehensive eye examination. Specialized tests, such as corneal pachymetry to measure corneal thickness and specular microscopy to assess the endothelial cell count, are often used to confirm the diagnosis and determine the severity of the condition.

 

Treatment

There is no cure for Fuchs' dystrophy, but treatments are available to manage symptoms and improve vision. In the early stages, hypertonic saline eye drops can help reduce corneal swelling.

 

Soft contact lenses or therapeutic bandage lenses may also provide relief. As the disease progresses, corneal transplant surgery might be necessary. Two primary types of corneal transplants are penetrating keratoplasty (full-thickness transplant) and Descemet's membrane endothelial keratoplasty (DMEK), which targets only the affected endothelial layer.

 

Living with Fuchs' dystrophy

Living with Fuchs' dystrophy requires regular monitoring and treatment adjustments by an eye care professional. While the condition can significantly impact quality of life, advances in surgical techniques offer hope for restored vision and improved outcomes for those affected by this challenging eye disease.

By Mr John Awad
Ophthalmology

Mr John Awad is a leading consultant ophthalmologist based in Shrewsbury and Macclesfield, who specialises in cataract, including refractive lens exchange, eye lid lift (blepharoplasty) and dry eyes, alongside ptosis (droopy eyes), watery eyes and oculoplastics. He privately practises at Nuffield Health Shrewsbury, Spire Regency Hospital Macclesfield, Spire Yale Hospital, Spire Healthcare Abergele Clinic and Leighton Hospital, while his NHS base is Mid Cheshire Hospitals NHS Foundation Trust.   

Mr Awad is highly educated, with an MB ChB from the University of Manchester and has further medical elective experience in ophthalmology at Norfolk and Norwich University Hospitals Trust and on the Cook Islands. He then went on to complete his post-graduate ophthalmic specialist training in the West Midlands Deanery and underwent a further fellowship in oculoplastic, lacrimal and orbital surgery at the Birmingham Midland Eye Centre.

Mr Awad has significant experience in teaching, and is a clinical supervisor and responsible for teaching ophthalmology trainees cataract and oculoplastic surgery. Furthermore, he's an examiner for the Royal College of Ophthalmologists (RCOphth). 

Mr Awad's clinical research has been published in various peer-reviewed journals, while he has also been invited to review articles and present at national and international conferences. He is a full member of the British Oculoplastic Surgical Society (BOPSS), which is a national governing society that upholds excellence in research, training and promotes the highest standard of clinical practice in the field of functional and aesthetic eyelid surgery. He's also a member of the British Medical Association (BMA), the Midland Ophthalmological Society (MOS) and General Medical Council (GMC).  

View Profile

Overall assessment of their patients


  • Related procedures
  • Microdermoabrasion
    Microneedling
    Dark circles
    Mesotherapy
    Facelift
    Neck lift
    Botulinum toxin (Botox™)
    Dermal fillers
    Peeling
    Facial paralysis
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.